PATENT CLAIM ANALYSIS

Application Number: 15989532
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "136100"]

Abstract:
Bispecific EGFR/c-Met antibodies and methods of making and using the molecules.

Claim (Index 5):
The bispecific antibody of  claim 4 , wherein the HC1 and the HC2 are an IgG1 isotype.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 93.0
- Lexical Diversity: 1.09091
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14283257', '15386195', '14086588', '14086250', '14085340']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8727347838912181
- 35 USC 102 Novelty (BERT): 0.6377670087951454
- Combined Prediction Score: 0.8492380063816107
- Mean Citation Score: 723.874022
- Max Citation Score: 927.17365
- Similarity Product: 564.5627322264432

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test